GREENHAVEN ASSOCIATES INC has opened a new $859.8M position in $BDX, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2026 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $BDX.
$BDX Hedge Fund Activity
We have seen 608 institutional investors add shares of $BDX stock to their portfolio, and 731 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GREENHAVEN ASSOCIATES INC added 5,681,708 shares (+inf%) to their portfolio in Q2 2026, for an estimated $859,812,871
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 4,140,223 shares (-99.6%) from their portfolio in Q1 2026, for an estimated $644,384,307
- BLACKROCK, INC. removed 1,495,294 shares (-5.4%) from their portfolio in Q1 2026, for an estimated $232,727,558
- ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 1,433,244 shares (-86.5%) from their portfolio in Q1 2026, for an estimated $223,070,096
- WELLINGTON MANAGEMENT GROUP LLP added 1,316,200 shares (+24.8%) to their portfolio in Q1 2026, for an estimated $204,853,367
- HOLOCENE ADVISORS, LP removed 1,088,801 shares (-93.4%) from their portfolio in Q1 2026, for an estimated $169,460,987
- MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 1,013,192 shares (-42.5%) from their portfolio in Q1 2026, for an estimated $157,693,202
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$BDX Insider Trading Activity
$BDX insiders have traded $BDX stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- THOMAS E JR POLEN (Chairman, CEO and President) sold 2,764 shares for an estimated $404,511
- MICHAEL DAVID GARRISON (EVP & Pres Med.Essntl&BioPharm) has made 0 purchases and 2 sales selling 2,200 shares for an estimated $326,854.
- BERTRAM L SCOTT sold 953 shares for an estimated $174,027
- MICHAEL FELD (EVP, Chief Revenue Officer) has made 0 purchases and 6 sales selling 449 shares for an estimated $70,939.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BDX Government Contracts
We have seen $123,329,416 of award payments to $BDX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PHARMACY INPATIENT AUTOMATION SUPPORT - ENTERPRISE MAINTENANCE AND SUPPORT SERVICES: $13,724,256
- INFUSION PUMPS AND SERVICES: $5,519,658
- INFUSION PUMPS MULTIPLE-AWARD IDIQ VISN 10 ORDER: $5,252,124
- INFUSION PUMPS: $5,057,297
- FLEET REPLACEMENT INFUSION PUMPS: $3,272,308
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $15,000 on 05/21.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 11 analysts offer price targets for $BDX in the last 6 months, with a median target of $175.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $180.0 on 07/06/2026
- Matt Miksic from Barclays set a target price of $204.0 on 05/11/2026
- Lawrence Biegelsen from Wells Fargo set a target price of $161.0 on 05/08/2026
- Joshua Jennings from TD Cowen set a target price of $163.0 on 05/04/2026
- Jason Bednar from Piper Sandler set a target price of $159.0 on 04/17/2026
- David Roman from Goldman Sachs set a target price of $167.0 on 04/10/2026
- David Toung from Argus Research set a target price of $180.0 on 03/23/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $BDX ticker page for more data.
